We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LJUIF market cap is 2.07B. The company's latest EPS is HKD 0.4441 and P/E is 1.58.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HKD (元) | HKD (元) | HKD (元) | HKD (元) | HKD (元) | |
| Total Revenue | 4.64B | 4.26B | 5.36B | 6.43B | 6.46B |
| Operating Income | 1.26B | 756.5M | 984.28M | 1.44B | 1.67B |
| Net Income | 1.14B | 611.97M | 785.53M | 1.12B | 1.32B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HKD (元) | HKD (元) | HKD (元) | HKD (元) | HKD (元) | |
| Total Assets | 7.72B | 9.25B | 10.71B | 10.97B | 11.97B |
| Total Liabilities | 2.54B | 3.34B | 4.22B | 4.42B | 4.7B |
| Total Equity | 5.19B | 5.92B | 6.49B | 6.55B | 7.27B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| HKD (元) | HKD (元) | HKD (元) | HKD (元) | HKD (元) | |
| Operating | 645.96M | 504.56M | 695.63M | 733.69M | 925.75M |
| Investing | -726.23M | -312.39M | -656.52M | -400.81M | -640.19M |
| Financing | 14.53M | 366.35M | 136.13M | -192.42M | -304.57M |
| Market Cap | 2.07B |
| Price to Earnings Ratio | 1.58 |
| Price to Sales Ratio | 0.32 |
| Price to Cash Ratio | 1.29 |
| Price to Book Ratio | 0.29 |
| Dividend Yield | - |
| Shares Outstanding | 2.97B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.6987 |
| 52 Week Low | 0.6987 |
| Spread (Intraday) | 0.33 (47.67%) |
| Company Name | Ssy Group Ltd (PK) |
| Address |
cricket square grand cayman KY1-1111 |
| Website | https://www.ssygroup.com.hk |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
